Asthma and Respiratory Disorders News

ANAHEIM, Calif. — A digital asthma self-management program reduced ED visit rates for adults with asthma on Medicaid, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Topline results from a phase 2b trial revealed that rademikibart led to improvements in lung function and asthma control in adults with moderate to severe persistent asthma compared with placebo.

This year’s asthma research covered a broad variety of topics, such as the effect of the family dog’s fur on long-term outcomes, asthma care in prison, fast food restaurants and the Canadian wildfires.

Innovation in asthma and allergy care continued in 2023. Healio’s most popular stories this year covered breakthroughs in immunotherapy treatments for food allergy and revised looks at common treatments for congestion and allergy.

Adults with moderate to severe persistent asthma receiving rademikibart every 2 weeks showed greater improvements in lung function at week 12 compared with patients assigned placebo, according to topline results from a phase 2b trial.

China had a higher asthma mortality rate than the United States between 1990 and 2019, driven by smoking, high BMI and age, but this gap narrowed with time, according to a study published in the Chinese Medical Journal.

ANAHEIM, Calif. — Although disparities remain in asthma care, innovative strategies may close these gaps, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

The U.K. Medicines and Healthcare products Regulatory Agency recently approved a phase 1 study that will test an inhaled mRNA-based drug as a treatment and prophylaxis of respiratory viral infections, according to a press release.

ANAHEIM, Calif. — Better biomarkers for diagnosis and prognosis are needed for better personalized asthma care, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

The historical climate events of the past summer may have been eye-opening for all, but the health of patients with respiratory diseases and conditions has been particularly threatened due to these exposures.